Older Patients Are Less Affected by Radiochemotherapeutic Treatment than Younger

Table 3

Chemotherapeutic characteristics of rectal cancer patients related to age groups.

Age category (years)	Rectal cancer patients ()	Chemotherapy completed () (%)	Reduced dose () (%)	Standard chemotherapy with 5FU/Oxaliplatin () (%)
<40	7	6 (85.7)	1 (14.3)	7 (100)
40–49	17	17 (94.1)	0 (0)	12 (70.6)
50–59	42	42 (100)	0 (0)	35 (83.3)
60–69	53	52 (94.3)	1 (1.9)	45 (84.9)
≥70	64	51 (68.8)	13 (20.3)	38 (59.4)
Total	183	168 (86.3)	15 (8.2)	137 (74.9)
<60 years	66	65 (97)	1 (1.5)	54 (81.8)
≥60 years	117	103 (80.3)	14 (12)	83 (70.9)